Nov 29, 2021 04:19 PM (GMT+8) · EqualOcean
Cailian news agency, Nov. 29 - Fangsheng pharmaceutical announced that the domestic drug registration application of "xuanqijiangu tablet" (formerly known as "jingule tablet") submitted by the company to the State Food and drug administration is in the state of "approval completed - pending certificate preparation".